In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
In a 72-week study, Zepbound's mean weight loss was 20.2%, while Wegovy's was 13.7% ... Second, the medicine everyone thought would take over the industry, Novo Nordisk's CagriSema, did not ...
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...